HYPERION DEFI, INC. Sale of Stock, Consideration Received on Transaction
HYPERION DEFI, INC. (HYPD) reported Sale of Stock, Consideration Received on Transaction of $21.80 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-03-30
- HYPERION DEFI, INC. sale of stock, consideration received on transaction for the quarter ending 2025-09-30 was $21.80M.
- HYPERION DEFI, INC. sale of stock, consideration received on transaction for the quarter ending 2025-06-30 was $2.60M.
- HYPERION DEFI, INC. sale of stock, consideration received on transaction for the quarter ending 2025-03-31 was $5.70M.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 3 month | Sale of Stock, Consideration Received on Transaction 6 month | Sale of Stock, Consideration Received on Transaction 9 month |
|---|---|---|---|---|
| 2025-09-30 | $21.80M 10-Q · filed 2025-11-14 | $24.40M derived: sum of 2 quarters · filed 2025-11-14 | $30.00M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-13 | $8.20M 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $5.70M 10-Q · filed 2025-05-19 | |||
| 2024-09-30 | $3.60M 10-Q · filed 2024-11-12 | |||
| 2024-08-21 | $4.50M 10-K · filed 2026-03-30 | |||
| 2024-07-01 | $4.30M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |